{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:01:54Z","timestamp":1790683314991,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["BioMolTox"],"award-info":[{"award-number":["BioMolTox"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["KK.01.1.1.02.0007"],"award-info":[{"award-number":["KK.01.1.1.02.0007"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","award":["IND2018\/BMD-9804"],"award-info":[{"award-number":["IND2018\/BMD-9804"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","award":["MINA-CM-S2022\/BMD-7236"],"award-info":[{"award-number":["MINA-CM-S2022\/BMD-7236"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tox.2026.154579","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:28:12Z","timestamp":1788305292000},"page":"154579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Potent inhibition and limited reactivation of human cholinesterases by cholesterol- and quinoline-based oximes"],"prefix":"10.1016","volume":"527","author":[{"given":"Petra","family":"Tuksar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8265-1901","authenticated-orcid":false,"given":"Goran","family":"\u0160inko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matea","family":"Kurtovi\u0107 Kod\u017eoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-4291","authenticated-orcid":false,"given":"Maja","family":"Katalini\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Toledano-Pinedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mourad","family":"Chioua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Marco-Contelles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9863-886X","authenticated-orcid":false,"given":"Zrinka","family":"Kovarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.tox.2026.154579_bib1","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.1523362113","article-title":"Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6","volume":"113","author":"Allgardsson","year":"2016","journal-title":"PNAS"},{"issue":"16","key":"10.1016\/j.tox.2026.154579_bib2","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1021\/acs.jmedchem.5b00755","article-title":"Cholesteronitrones for stroke","volume":"58","author":"Ayuso","year":"2015","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.tox.2026.154579_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/biof.70071","article-title":"BACE1: biological functions and involvement in the pathophysiology of Alzheimer's disease and other neurological disorders","volume":"51","author":"Bartoli\u0107","year":"2025","journal-title":"BioFactors"},{"issue":"2","key":"10.1016\/j.tox.2026.154579_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3390\/ph3020345","article-title":"Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound","volume":"3","author":"Bordet","year":"2010","journal-title":"Pharmaceuticals"},{"issue":"2","key":"10.1016\/j.tox.2026.154579_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1124\/jpet.107.123000","article-title":"Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis","volume":"322","author":"Bordet","year":"2007","journal-title":"J. Pharm. Exp. Ther."},{"key":"10.1016\/j.tox.2026.154579_bib6","doi-asserted-by":"crossref","unstructured":"Brooks, B.R., Bruccoleri, R.E., Olafson, B.D., States, D.J., Swaminathan, S., Karplus, M. (1983). CHARMM: A Program for Macromolecular Energy, Minimization, and Dynamics Calculations. https:\/\/doi.org\/10.1002\/jcc.540040211.","DOI":"10.1002\/jcc.540040211"},{"issue":"5","key":"10.1016\/j.tox.2026.154579_bib7","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00204-025-03985-6","article-title":"Click-chemistry-derived oxime library reveals efficient reactivators of nerve agent-inhibited butyrylcholinesterase suitable for pseudo-catalytic bioscavenging","volume":"99","author":"\u010cade\u017e","year":"2025","journal-title":"Arch. Tox"},{"issue":"22","key":"10.1016\/j.tox.2026.154579_bib8","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.1021\/acs.jmedchem.6b00670","article-title":"Small molecules in development for the treatment of spinal muscular atrophy","volume":"59","author":"Calder","year":"2016","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.tox.2026.154579_bib9","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1021\/acs.jmedchem.8b01987","article-title":"New quinolylnitrones for stroke therapy: antioxidant and neuroprotective (Z)- N- tert-butyl-1-(2-chloro-6-methoxyquinolin-3-yl)methanimine oxide as a new lead-compound for ischemic stroke treatment","volume":"62","author":"Chioua","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2026.154579_bib10","article-title":"Crystal structure of human acetylcholinesterase","author":"Dym","year":"2015","journal-title":"Isr. Struct. Proteom. Cent."},{"issue":"3","key":"10.1016\/j.tox.2026.154579_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0169-409X(02)00004-2","article-title":"Prediction of intestinal permeability","volume":"54","author":"Egan","year":"2002","journal-title":"Adv. Drug. Del. Rev."},{"issue":"2","key":"10.1016\/j.tox.2026.154579_bib12","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.tox.2026.154579_bib13","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jnc.15719","article-title":"Pathway-based integration of multi-omics data reveals lipidomics alterations validated in an Alzheimer\u2019s disease mouse model and risk loci carriers","volume":"164","author":"Garcia-Segura","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.tox.2026.154579_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104633","article-title":"Insights of 8-hydroxyquinolines: a novel target in medicinal chemistry","volume":"108","author":"Gupta","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"23","key":"10.1016\/j.tox.2026.154579_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262311506","article-title":"Neuroprotective and antioxidant properties of different novel steroid-derived nitrones and oximes on cerebral ischemia in vitro","volume":"26","author":"Izquierdo-Bermejo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.tox.2026.154579_bib16","doi-asserted-by":"crossref","first-page":"16349","DOI":"10.1021\/acs.jmedchem.1c01318","article-title":"Novel antimicrobial 8-hydroxyquinoline-based agents: current development, structure\u2013activity relationships, and perspectives","volume":"64","author":"Joaquim","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tox.2026.154579_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.taap.2016.09.015","article-title":"A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers","volume":"310","author":"Katalini\u0107","year":"2016","journal-title":"Tox Appl. Pharmacol."},{"issue":"5","key":"10.1016\/j.tox.2026.154579_bib18","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.apsb.2023.01.013","article-title":"8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases","volume":"13","author":"Knez","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.tox.2026.154579_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2026.118895","article-title":"N,N\u2032-dibenzyl imidazolium oximes are potent reactivators of organophosphate-inhibited human butyrylcholinesterase","volume":"313","author":"Koli\u0107","year":"2026","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tox.2026.154579_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111649","article-title":"Kinetic and structural evidence for specific DMSO interference with reversible binding of uncharged bis-oximes to hAChE and their reactivation kinetics of OP-hAChE","volume":"419","author":"Koli\u0107","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.tox.2026.154579_bib21","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/biof.2048","article-title":"N-methyl-D-aspartate receptors: structure, function, and role in organophosphorus compound poisoning","volume":"50","author":"Koli\u0107","year":"2024","journal-title":"BioFactors"},{"issue":"5","key":"10.1016\/j.tox.2026.154579_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.3390\/biom14050588","article-title":"Cholesterol oxime olesoxime assessed as a potential ligand of human cholinesterases","volume":"14","author":"Koli\u0107","year":"2024","journal-title":"Biomolecules"},{"issue":"16","key":"10.1016\/j.tox.2026.154579_bib23","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1002\/chem.201805051","article-title":"Reversal of tabun toxicity enabled by a triazole-annulated oxime library\u2014reactivators of acetylcholinesterase","volume":"25","author":"Kovarik","year":"2019","journal-title":"Chemistry"},{"key":"10.1016\/j.tox.2026.154579_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111762","article-title":"Outlining the A-series of organophosphorus compounds: cholinesterase inhibition, reactivation, cytotoxicity, and acute toxicity in mice","volume":"421","author":"Kovarik","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.tox.2026.154579_bib25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/jnc.15887","article-title":"Recent advances in cholinergic mechanisms as reactions to toxicity, stress, and neuroimmune insults","volume":"168","author":"Kovarik","year":"2024","journal-title":"J. Neurochem."},{"issue":"11","key":"10.1016\/j.tox.2026.154579_bib26","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1021\/bi036191a","article-title":"Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates","volume":"43","author":"Kovarik","year":"2004","journal-title":"Biochemistry"},{"issue":"40","key":"10.1016\/j.tox.2026.154579_bib27","article-title":"Broad-Spectrum antidote discovery by untangling the reactivation mechanism of nerve-agent-inhibited acetylcholinesterase","volume":"28","author":"Lindgren","year":"2022","journal-title":"Chemistry"},{"key":"10.1016\/j.tox.2026.154579_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111767","article-title":"The ionizing zwitterionic oxime antidote attenuates gliosis in mice exposed to sarin","volume":"421","author":"Ma\u010dek Hrvat","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.tox.2026.154579_bib29","first-page":"1","article-title":"Structure-guided modification of a lead cholinesterase-targeting oxime to improve peripheral site binding","volume":"77","author":"Marakovi\u0107","year":"2026","journal-title":"Arh. Hig. Rad. Toksikol."},{"key":"10.1016\/j.tox.2026.154579_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111497","article-title":"Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer's disease","volume":"413","author":"Marco-Contelles","year":"2025","journal-title":"Chem. -Biol. Interact."},{"key":"10.1016\/j.tox.2026.154579_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110620","article-title":"Evaluation of 4-aminoquinoline derivatives with an N-octylamino spacer as potential multi-targeting ligands for the treatment of Alzheimer\u2019s disease","volume":"382","author":"Mato\u0161evi\u0107","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.tox.2026.154579_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3390\/biom14060679","article-title":"New heterostilbene and triazole oximes as potential CNS-active and cholinesterase-targeted therapeutics","volume":"14","author":"Mlaki\u0107","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.tox.2026.154579_bib33","article-title":"Validation of the General Purpose QUANTAa3.2\/CHARMma Force Field\"","author":"Momanyt","year":"1991","journal-title":"J. Comput. Chem."},{"issue":"5","key":"10.1016\/j.tox.2026.154579_bib34","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1002\/jhet.5570210548","article-title":"Novel synthesis of isoxazolo[5,4-b] quinolines","volume":"21","author":"Neelima","year":"1984","journal-title":"J. Heterocycl. Chem."},{"issue":"9","key":"10.1016\/j.tox.2026.154579_bib35","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1107\/S1744309107037335","article-title":"Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase","volume":"63","author":"Ngamelue","year":"2007","journal-title":"Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun."},{"issue":"4","key":"10.1016\/j.tox.2026.154579_bib36","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1602\/neurorx.2.4.541","article-title":"Medicinal chemical properties of successful central nervous system drugs","volume":"2","author":"Pajouhesh","year":"2005","journal-title":"NeuroTherapeutics"},{"issue":"18","key":"10.1016\/j.tox.2026.154579_bib37","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1007\/s00018-019-03386-w","article-title":"Molecular mechanism of olesoxime-mediated neuroprotection through targeting \u03b1-synuclein interaction with mitochondrial VDAC","volume":"77","author":"Rovini","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.tox.2026.154579_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0009-2797(99)00014-9","article-title":"Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase","volume":"119","author":"Saxena","year":"1999","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.tox.2026.154579_bib39","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0009-2797(99)00020-4","article-title":"Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4\u2032-bipyridine and by a coumarin derivative","volume":"119\u2013120","author":"Simeon-Rudolf","year":"1999","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2026.154579_bib40","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.cbi.2019.05.047","article-title":"Assessment of scoring functions and in silico parameters for AChE-ligand interactions as a tool for predicting inhibition potency","volume":"308","author":"\u0160inko","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.tox.2026.154579_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110656","article-title":"Modeling of a near-attack conformation of oxime in phosphorylated acetylcholinesterase via a reactivation product, a phosphorylated oxime","volume":"383","author":"\u0160inko","year":"2023","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.tox.2026.154579_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ab.2007.07.023","article-title":"Limitation of the Ellman method: Cholinesterase activity measurement in the presence of oximes","volume":"370","author":"\u0160inko","year":"2007","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tox.2026.154579_bib43","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejmech.2014.04.078","article-title":"Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer\u2019s disease","volume":"80","author":"Wang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.tox.2026.154579_bib44","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bcp.2019.07.002","article-title":"Olesoxime in neurodegenerative diseases: scrutinising a promising drug candidate","volume":"168","author":"Weber","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.tox.2026.154579_bib45","first-page":"203","article-title":"Effects of N-alkyl quaternary quinuclidines on oxidative stress biomarkers in SH-SY5Y cells","volume":"76","author":"Zandona","year":"2025","journal-title":"Arh. Hig. Rad. Toksikol."},{"issue":"4","key":"10.1016\/j.tox.2026.154579_bib46","first-page":"277","article-title":"Cytotoxicity-related effects of imidazolium and chlorinated bispyridinium oximes in SH-SY5Y cells","volume":"73","author":"Zandona","year":"2022","journal-title":"Arh. Hig. Rad. Toksikol."},{"issue":"38","key":"10.1016\/j.tox.2026.154579_bib47","doi-asserted-by":"crossref","first-page":"9675","DOI":"10.1002\/chem.201801394","article-title":"Potent 3-hydroxy-2-pyridine aldoxime reactivators of organophosphate-inhibited cholinesterases with predicted blood\u2013brain barrier penetration","volume":"24","author":"Zorbaz","year":"2018","journal-title":"Chemistry"},{"issue":"1\u20132","key":"10.1016\/j.tox.2026.154579_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.18054\/pb.v121-122i1-2.10623","article-title":"Neuropharmacology: oxime antidotes for organophosphate pesticide and nerve agent poisoning","volume":"121\u2013122","author":"Zorbaz","year":"2020","journal-title":"Per Biol."},{"issue":"23","key":"10.1016\/j.tox.2026.154579_bib49","doi-asserted-by":"crossref","first-page":"10753","DOI":"10.1021\/acs.jmedchem.8b01398","article-title":"Pyridinium oximes with ortho-positioned chlorine moiety exhibit improved physicochemical properties and efficient reactivation of human acetylcholinesterase inhibited by several nerve agents","volume":"61","author":"Zorbaz","year":"2018","journal-title":"J. Med. Chem."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X26001861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X26001861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:27:39Z","timestamp":1790681259000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X26001861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":49,"alternative-id":["S0300483X26001861"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2026.154579","relation":{},"ISSN":["0300-483X"],"issn-type":[{"value":"0300-483X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potent inhibition and limited reactivation of human cholinesterases by cholesterol- and quinoline-based oximes","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2026.154579","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154579"}}